Northwestern University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).

1,209 total trials 187 currently recruiting 767 completed early-phase tilt top decile by trial count

Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.

Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.

Top-decile sponsor footprint

Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 50/100

767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,209 total, page 8 of 25

COMPLETED NA

Technology Enabled Services to Enhance Depression Care

NCT05406791

COMPLETED NA

STEPUP Clinical Trial

NCT05445375

TERMINATED Phase 4

Angiotensin II for Distributive Shock

NCT04904562

COMPLETED NA

Improving Human Cerebrovascular Function Using Acute Intermittent Hypoxia

NCT05164705

COMPLETED NA

Wolf 24 F vs. Storz 28 F Laser Sheath Size for HoLEP

NCT05308017

COMPLETED NA

Adolescent and Child Suicide Prevention in Routine Clinical Encounters

NCT04844021

TERMINATED NA

PROphylactic Manual RotatIon in the Second stagE of Labor

NCT05175040

COMPLETED

Advance Provision of Postpartum Emergency Contraception and Its Effects on Reproductive Autonomy

NCT05285605

COMPLETED NA

EHR-based Patient Identification and Panel Management of Patients With Iron Deficiency Anemia

NCT05365308

COMPLETED NA

Reactivating Specific Memories During Sleep in Conjunction with a Suppression Context

NCT04702750

COMPLETED NA

Cortical Contributions to Frequency Following Responses and Modulation

NCT05010473

COMPLETED NA

ED Physical Therapy for Chronic Low Back Pain

NCT05206630

COMPLETED NA

ANNE Diagnostic Agreement With Home Sleep Testing

NCT05421754

COMPLETED NA

MRI Study of High Definition Transcranial Electrical Stimulation in Chronic Tinnitus (MRI HDtES-T)

NCT05120037

COMPLETED

Postpartum Pain Experience and Attitudes About Opioid Prescribing

NCT05202795

COMPLETED NA

Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian Cancer

NCT05092763

COMPLETED NA

Psychological Well-being and Burnout in Healthcare Workers During the COVID-19 (Coronavirus Disease 2019) Pandemic

NCT05394051

COMPLETED

Immune Response to SARS-CoV-2/COVID-19 Vaccination in Sarcoidosis

NCT05089565

COMPLETED

Emergency Department Vestibular Rehabilitation Therapy for Dizziness and Vertigo

NCT05122663

TERMINATED

A Pilot Study to Determine the Feasibility, Acceptance, and Effectiveness of In-vitro Maturation in Patients Without IVF Coverage

NCT05793931

COMPLETED Phase 3

The Use of Pecs Blocks in Combination With Exparel in Breast Reconstruction Surgery

NCT05171179

COMPLETED Phase 4

Gastric Volumes by US in Term Parturients Undergoing CS With and Without Metoclopramide

NCT05033041

COMPLETED Phase 4

Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP)

NCT05082142

COMPLETED NA

Developing and Pre-Testing an eHealth Group Intervention for Young Adult Cancer Survivors

NCT05054569

TERMINATED Phase 4

Sciatic Block in Contralateral Limb Phantom and Residual Limb Pain

NCT05046639

COMPLETED

People of Color and Dermatology: A Deeper Look at Patients' Perceptions of Care and the Need for Greater Diversity in Dermatology

NCT04991285

COMPLETED NA

ED Physical Therapy for Acute Low Back Pain

NCT04921449

COMPLETED

Consumer Knowledge, Attitude, and Behavior Towards Aging Skin

NCT04999748

COMPLETED NA

Hippocampal Stimulation in Chronic Low Back Pain

NCT04888494

COMPLETED NA

Testing the Contribution of Orbitofrontal Cortex Networks to Reward Identity Learning

NCT04926961

COMPLETED

Advanced Multimodal Wireless Vital Signs Monitoring for Patients With Asthma and Anaphylaxis

NCT04360213

COMPLETED NA

Accupressure of P6 to Reduce Nausea During Cesarean Section

NCT04799587

COMPLETED NA

Memory and Fear Study (Fear of Memory Loss Study)

NCT04821960

COMPLETED NA

Comparative Study of the ANNE™ One System to Diagnose Obstructive Sleep Apnea

NCT04643782

COMPLETED NA

Reinstatement of Context During Sleep and Its Subsequent Effect on Memory: an fMRI Study

NCT04702724

COMPLETED NA

Hearing Aid Processing and Working Memory in Realistic Spatial Conditions

NCT04521166

COMPLETED Early Phase 1

An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses

NCT04549792

COMPLETED NA

A Research Study for Latina Women With Breast Cancer

NCT04861896

TERMINATED NA

Tracking Mood and Language Change Across a Phone-based Mindfulness Intervention

NCT04861844

COMPLETED Phase 2

Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT04753216

COMPLETED NA

Measuring Dysphagia After ACDF Surgery Through A Novel Wearable Sensor

NCT04921800

COMPLETED NA

Feasibility of the Implementation of Tools for Heart Failure Risk Prediction

NCT04684264

COMPLETED NA

Promoting Infant-Directed Speech in Ghana

NCT04807907

COMPLETED Phase 2

Romosozumab in Women With Chronic SCI

NCT04708886

COMPLETED NA

Testing Intervention Strategies for Addressing Obesity and Binge Eating

NCT04771455

COMPLETED

Hypertension Management Using Remote Patient Monitoring: Study 2

NCT04764318

TERMINATED NA

Utilizing Topical Sodium Hypochlorite to Ameliorate Radiation Dermatitis

NCT04630821

COMPLETED NA

Olfactory Decision-making and Deprived Sleep

NCT05093413

COMPLETED NA

Examining Self-tracking Behaviors in a Mobile Intervention for Binge Eating and Weight Management

NCT04711577

COMPLETED NA

VerTouch Device: A Prospective Randomized Controlled Trial

NCT04630171

← Previous Page 8 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 132
Phase 2 163
Phase 3 36
Phase 4 78

What is open in the Northwestern University pipeline

187 recruiting of 1,209 indexed (15% open); 767 completed (63%).

Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).

Top condition: Depression (11 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwestern University: open-pipeline peers nationwide

Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20% Total trials Recruiting share Northwestern UniversityEmory UniversityUniversity of PittsburghNYU Langone HealthUniversity of Alabama at BirminghamBrigham and Women's HospitalIncyte CorporationNationwide Children's HospitalUniversity of Michigan Rogel Cancer Center
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,209 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Northwestern University page

1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.

  • 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.